134 related articles for article (PubMed ID: 19642399)
1. Pharmacokinetics of detomidine administered to horses at rest and after maximal exercise.
Hubbell JA; Sams RA; Schmall LM; Robertson JT; Hinchcliff KW; Muir WW
Equine Vet J; 2009 May; 41(5):419-22. PubMed ID: 19642399
[TBL] [Abstract][Full Text] [Related]
2. Cardiorespiratory and metabolic effects of xylazine, detomidine, and a combination of xylazine and acepromazine administered after exercise in horses.
Hubbell JA; Hinchcliff KW; Schmall LM; Muir WW; Robertson JT; Sams RA
Am J Vet Res; 1999 Oct; 60(10):1271-9. PubMed ID: 10791941
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of detomidine and its metabolites following intravenous and intramuscular administration in horses.
Grimsrud KN; Mama KR; Thomasy SM; Stanley SD
Equine Vet J; 2009 Apr; 41(4):361-5. PubMed ID: 19562897
[TBL] [Abstract][Full Text] [Related]
4. The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses.
Paine SW; Bright J; Scarth JP; Hincks PR; Pearce CM; Hannan C; Machnik M; Hillyer L
J Vet Pharmacol Ther; 2020 Mar; 43(2):162-170. PubMed ID: 32012314
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
Dimaio Knych HK; Stanley SD
Am J Vet Res; 2011 Oct; 72(10):1378-85. PubMed ID: 21962281
[TBL] [Abstract][Full Text] [Related]
6. The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.
Knych HK; Steffey EP; Stanley SD
Vet Anaesth Analg; 2012 May; 39(3):221-9. PubMed ID: 22405129
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations, behavioural and physiological effects following intravenous and intramuscular detomidine in horses.
Mama KR; Grimsrud K; Snell T; Stanley S
Equine Vet J; 2009 Nov; 41(8):772-7. PubMed ID: 20095225
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pharmacokinetics of detomidine in the horse and cow.
Salonen JS; Vähä-Vahe T; Vainio O; Vakkuri O
J Vet Pharmacol Ther; 1989 Mar; 12(1):65-72. PubMed ID: 2704064
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the sedative effects and pharmacokinetics of detomidine gel administered intravaginally to horses.
Seddighi R; Knych HK; Cox SK; Sun X; Moorhead KA; Doherty TJ
Vet Anaesth Analg; 2019 Nov; 46(6):772-779. PubMed ID: 31474339
[TBL] [Abstract][Full Text] [Related]
10. Hepatic blood flow in horses during the recuperative period from maximal exercise.
Dyke TM; Hubbell JA; Sams RA; Hinchcliff KW
Am J Vet Res; 1998 Nov; 59(11):1476-80. PubMed ID: 9829410
[TBL] [Abstract][Full Text] [Related]
11. Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine.
Vainionpää MH; Raekallio MR; Pakkanen SA; Ranta-Panula V; Rinne VM; Scheinin M; Vainio OM
Vet Anaesth Analg; 2013 May; 40(3):257-64. PubMed ID: 23368795
[TBL] [Abstract][Full Text] [Related]
12. Effect of creatine supplementation on muscle metabolic response to a maximal treadmill exercise test in Standardbred horses.
Schuback K; Essén-Gustavsson B; Persson SG
Equine Vet J; 2000 Nov; 32(6):533-40. PubMed ID: 11093628
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose atropine administration on dobutamine dose requirement in horses anesthetized with detomidine and halothane.
Weil AB; Keegan RD; Greene SA
Am J Vet Res; 1997 Dec; 58(12):1436-9. PubMed ID: 9401695
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the in vivo interactions between detomidine and methadone in horses: Pharmacokinetic and pharmacodynamic modelling.
Gozalo-Marcilla M; Luna SPL; Moreira da Silva R; Crosignani N; Lopes NP; Taylor PM; Pelligand L
Equine Vet J; 2019 Jul; 51(4):517-529. PubMed ID: 30298682
[TBL] [Abstract][Full Text] [Related]
15. Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay.
Wood T; Tai CL; Taylor DG; Woods WE; Wang CJ; Houtz PK; Tai HH; Weckman TJ; Yang JM; Sturma L
Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):263-79. PubMed ID: 2711028
[TBL] [Abstract][Full Text] [Related]
16. Identification of detomidine carboxylic acid as the major urinary metabolite of detomidine in the horse.
Salonen JS; Vuorilehto L; Gilbert M; Maylin GA
Eur J Drug Metab Pharmacokinet; 1992; 17(1):13-20. PubMed ID: 1499593
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
Knych HK; Vidal MA; Casbeer HC; McKemie DS
Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
[TBL] [Abstract][Full Text] [Related]
18. Effects of three antagonists on selected pharmacodynamic effects of sublingually administered detomidine in the horse.
Knych HK; Stanley SD
Vet Anaesth Analg; 2014 Jan; 41(1):36-47. PubMed ID: 24134603
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of detomidine administered sublingually to horses as an oromucosal gel.
Kaukinen H; Aspegrén J; Hyyppä S; Tamm L; Salonen JS
J Vet Pharmacol Ther; 2011 Feb; 34(1):76-81. PubMed ID: 21219348
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibition in thoroughbred horses augments O2 extraction at rest and submaximal exercise, but not during short-term maximal exercise.
Manohar M; Goetz TE; Hassan AS
Equine Vet J Suppl; 2006 Aug; (36):481-6. PubMed ID: 17402470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
